John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Fate Therapeutics
FATE
$306M
| $1.96M | 0.01% |
172,845
+82,141
| +91% | +$905K |
|
1627
CALL
Roper Technologies
ROP
$40.9B
| $1.96M | 0.01% |
7,100
+2,600
| +58% | +$717K |
|
1628
Myers Industries
MYE
$1.23B
| $1.96M | 0.01% |
101,933
+62,491
| +158% | +$1.33M |
|
1629
CALL
Core Laboratories
CLB
$553M
| $1.96M | 0.01% |
15,500
-22,100
| -59% | -$2.69M |
|
1630
Mativ Holdings
MATV
$682M
| $1.96M | 0.01% |
44,739
+38,212
| +585% | +$1.62M |
|
1631
CALL
Packaging Corp of America
PKG
$22B
| $1.96M | 0.01% |
17,500
-5,200
| -23% | -$607K |
|
1632
PUT
Weyerhaeuser
WY
$17.6B
| $1.95M | 0.01% |
53,400
-25,400
| -32% | -$929K |
|
1633
Federal Signal
FSS
$7.36B
| $1.95M | 0.01% |
83,515
+18,766
| +29% | +$437K |
|
1634
CGI
GIB
$15.4B
| $1.95M | 0.01% |
+30,699
| New | +$1.85M |
|
1635
CALL
Cleveland-Cliffs
CLF
$6.57B
| $1.94M | 0.01% |
230,400
+25,500
| +12% | +$203K |
|
|
LBAI
1636
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.94M | 0.01% |
+97,737
| New | +$1.96M |
|
|
JWN
1637
PUT
DELISTED
Nordstrom
JWN
| $1.94M | 0.01% |
+37,400
| New | +$1.85M |
|
1638
Inogen
INGN
$147M
| $1.94M | 0.01% |
10,383
+931
| +10% | +$155K |
|
1639
PUT
Kroger
KR
$35.8B
| $1.93M | 0.01% |
67,900
+24,400
| +56% | +$614K |
|
1640
Marriott International
MAR
$93.3B
| $1.93M | 0.01% |
15,241
-362,213
| -96% | -$49.2M |
|
|
AKRX
1641
DELISTED
Akorn Inc
AKRX
| $1.93M | 0.01% |
116,215
+99,835
| +609% | +$1.53M |
|
|
ZAGG
1642
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $1.93M | 0.01% |
111,323
-99,733
| -47% | -$1.43M |
|
1643
Resources Connection
RGP
$147M
| $1.93M | 0.01% |
113,922
+78,290
| +220% | +$1.28M |
|
1644
Clearwater Paper
CLW
$351M
| $1.92M | 0.01% |
83,264
+53,608
| +181% | +$1.47M |
|
1645
New Mountain Finance
NMFC
$719M
| $1.92M | 0.01% |
141,417
-39,114
| -22% | -$531K |
|
|
PS
1646
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $1.92M | 0.01% |
+78,312
| New | +$1.88M |
|
|
PCH
1647
DELISTED
PotlatchDeltic
PCH
| $1.91M | 0.01% |
37,523
-211,689
| -85% | -$10.7M |
|
1648
Scansource
SCSC
$1.14B
| $1.91M | 0.01% |
47,339
+15,379
| +48% | +$580K |
|
|
VSM
1649
DELISTED
Versum Materials, Inc.
VSM
| $1.91M | 0.01% |
+51,365
| New | +$1.96M |
|
1650
Mueller Water Products
MWA
$3.89B
| $1.91M | 0.01% |
162,693
-329,618
| -67% | -$3.68M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.